首页|circlARS:a potential plasma biomarker for diagnosing non-small cell lung cancer

circlARS:a potential plasma biomarker for diagnosing non-small cell lung cancer

扫码查看
原文链接
  • NETL
  • NSTL
  • 万方数据
Non-small cell lung cancer(NSCLC)is one of the most prevalent cancers in the world,and early diagnosis can effectively improve patient survival.Here,differentially expressed circlARS genes are screened from the sequen-cing results,and their molecular characteristics are examined by Sanger sequencing,RNase R assay,agarose gel electrophoresis(AGE),and fluorescence in situ hybridization(FISH).Real-time fluorescence quantitative poly-merase chain reaction(qRT-PCR)is performed to detect the expression level of circlARS.The diagnostic value of the signature is analyzed using a subject operating characteristic(ROC)curve.Moreover,plasma is collected from postsurgical,chemotherapy,and relapse patients to investigate the prognostic value of circlARS in NSCLC.The expression of circlARS is greater in both the plasma and tissues of NSCLC patients than in those of healthy individuals,and could be used to distinguish NSCLC patients from patients with benign pulmonary disease(BPD),small cell lung cancer(SCLC)patients,and healthy individuals.The expression level of circlARS relatively decreases after antitumor therapy,such as chemotherapy,and relatively increases after recurrence.ROC analysis reveals that circIARS has better detection efficiency than traditional markers.In addition,circlARS expression level is strongly correlated with several clinicopathological parameters.Finally,we tentatively predict the downstream miRNAs or RBP that might bind to circlARS.Plasma circlARS is significantly greater in NSCLC patients and has good stability and specificity as a diagnostic marker,which could aid in the adjuvant diagnosis and dynamic monitoring of NSCLC.

biomarkercirclARSdiagnosisnon-small cell lung cancerprognosis

Qi Zhang、Xinfeng Fan、Xinyu Zhang、Shaoqing Ju

展开 >

Medical School of Nantong University,Nantong University,Department of Laboratory Medicine,Affiliated Hospital of Nantong University,Nantong 226001,China

Medical School of Nantong University,Nantong University,Nantong 226001,China

Research Center of Clinical Medicine,Affiliated Hospital of Nantong University,Nantong 226001,China

Institute of Urology,Lanzhou University Second Hospital

Key Laboratory of Gansu Province for Urological Diseases

Gansu Nephro-Urological Clinical Center,Lanzhou 730030,China

展开 >

国家自然科学基金国家自然科学基金Jiangsu Provincial Medical Key Discipline(Laboratory)Science and Technology Project of Jiangsu Province

8227241182072363ZDXK202240BE2023741

2024

10.3724/abbs.2024043

生物化学与生物物理学报(英文版)
中国科学院上海生物化学研究所

生物化学与生物物理学报(英文版)

CSTPCD
影响因子：0.772
ISSN：1672-9145
年,卷(期)：2024.56(6)
  • 1